Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Toshio Fujino"'
Autor:
Takamasa Koga, MD, PhD, Junichi Soh, MD, PhD, Akira Hamada, MD, PhD, Yuki Miyano, MS, Toshio Fujino, MD, PhD, Keiko Obata, Shuta Ohara, MD, PhD, Masaya Nishino, MD, PhD, Masato Chiba, MD, PhD, Masaki Shimoji, MD, PhD, Toshiki Takemoto, MD, PhD, Kenichi Suda, MD, PhD, Kazuko Sakai, MD, PhD, Hidenori Sato, PhD, Tetsuya Mitsudomi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 9, Pp 100554- (2023)
Introduction: Lung tumor organoids (LTOs) have attracted attention as in vitro preclinical models; however, their clinical and experimental applications have not been fully established. Methods: We attempted to establish LTOs from resected specimens
Externí odkaz:
https://doaj.org/article/e9026793576d4c6aace4c65a0c8269ab
Autor:
Toshio Fujino, Kenichi Suda, Takamasa Koga, Akira Hamada, Shuta Ohara, Masato Chiba, Masaki Shimoji, Toshiki Takemoto, Junichi Soh, Tetsuya Mitsudomi
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-14 (2022)
Abstract Background Capmatinib and tepotinib are guideline-recommended front-line treatments for non-small-cell lung cancer (NSCLC) patients with MET exon 14 skipping mutations (METex14). However, the emergence of acquired resistance to capmatinib/te
Externí odkaz:
https://doaj.org/article/91f7932bd36f4d28ab9a6bce380f3ecc
Autor:
Masaya Nishino, Kenichi Suda, Takamasa Koga, Shuta Ohara, Toshio Fujino, Junichi Soh, Vijaya Tirunagaru, Avanish Vellanki, Robert C. Doebele, Tetsuya Mitsudomi
Publikováno v:
Thoracic Cancer, Vol 12, Iss 10, Pp 1511-1516 (2021)
Abstract Background Approximately 10% of non‐small cell lung cancers (NSCLCs) that harbor epidermal growth factor receptor (EGFR) gene mutations have in‐frame insertions in exon 20 of the EGFR gene. These tumors do not usually respond to currentl
Externí odkaz:
https://doaj.org/article/113f3c44e4bf4bd88a1b39cc70faedeb
Autor:
Akira Hamada, MD, Kenichi Suda, MD, PhD, Toshio Fujino, MD, PhD, Masaya Nishino, MD, PhD, Shuta Ohara, MD, PhD, Takamasa Koga, MD, PhD, Takanobu Kabasawa, MD, PhD, Masato Chiba, MD, PhD, Masaki Shimoji, MD, PhD, Makoto Endoh, MD, PhD, Toshiki Takemoto, MD, PhD, Junichi Soh, MD, PhD, Naoki Yanagawa, MD, PhD, Satoshi Shiono, MD, PhD, Tetsuya Mitsudomi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 5, Pp 100321- (2022)
Introduction: Recent studies have suggested that including presence or absence of ground-glass opacity (GGO) may improve the tumor descriptor (T descriptor) classification in clinical stage I NSCLC. In this study, we analyzed prognostic implications
Externí odkaz:
https://doaj.org/article/e3038b81b06d4260b05a610326300a03
Autor:
Shuta Ohara, Kenji Tomizawa, Shigeki Shimizu, Kenichi Suda, Toshio Fujino, Akira Hamada, Takamasa Koga, Masaya Nishino, Yoshihisa Kobayashi, Katsuaki Sato, Masato Chiba, Masaki Shimoji, Toshiki Takemoto, Junichi Soh, Tetsuya Mitsudomi
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-4 (2019)
Abstract Background A total of 75% of patients with Sjögren’s syndrome are complicated with pulmonary lesions, of which 12% are lymphoma and 6% are amyloid nodules; the coexistence of both is considered to be rare. Case presentation A 67-year-old
Externí odkaz:
https://doaj.org/article/5a843bab51b7499ab8dcdf89c1b00bd6
Autor:
Yasunori Kaminuma, Masayuki Tanahashi, Haruhiro Yukiue, Eriko Suzuki, Naoko Yoshii, Toshio Fujino, Hiroshi Ogawa, Hiroshi Niwa
Publikováno v:
Journal of Medical Case Reports, Vol 13, Iss 1, Pp 1-4 (2019)
Abstract Introduction Micronodular thymoma with lymphoid stroma is a rare subtype of thymoma. Here we report a case of micronodular thymoma with lymphoid stroma that was completely resected after incomplete resection 10 years earlier. Case presentati
Externí odkaz:
https://doaj.org/article/c2425ad9fe0d4528818e41115d6bd467
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100134- (2021)
Externí odkaz:
https://doaj.org/article/4b022acf6d254a20b76e963347cc6a36
Autor:
Toshio Fujino, Masayuki Tanahashi, Haruhiro Yukiue, Eriko Suzuki, Naoko Yoshii, Masayuki Shitara, Yasunori Kaminuma, Hiroshi Niwa
Publikováno v:
Surgical Case Reports, Vol 4, Iss 1, Pp 1-5 (2018)
Abstract Background Left sleeve pneumonectomy is a challenging operation that requires individualized approaches. Here, we present a new minimally invasive combined thoracoscopic approach. Case presentation A 61-year-old woman was diagnosed with trac
Externí odkaz:
https://doaj.org/article/377923a4f10e4ebbb7b36f4ad9fd541c
Autor:
Masaya Nishino, Kenichi Suda, Junichi Soh, Akira Hamada, Toshio Fujino, Avanish Vellanki, Tetsuya Mitsudomi, Shuta Ohara, Takamasa Koga, Robert C. Doebele, Vijaya G. Tirunagaru
Publikováno v:
Translational Lung Cancer Research. 10:3659-3670
Background HER2 (ERBB2) activating mutations are present in 2-3% of lung adenocarcinomas; however, no targeted therapy is approved for HER2-altered lung cancers. A novel pan-HER inhibitor, tarloxotinib, is designed to release the active form (tarloxo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76839986160a3db63314c254fef11d0f
https://doi.org/10.21037/tlcr-21-216
https://doi.org/10.21037/tlcr-21-216
Autor:
Akira Hamada, Toshio Fujino, Masaki Shimoji, Junichi Soh, Masato Chiba, Kenichi Suda, Takamasa Koga, Shuta Ohara, Kenji Tomizawa, Toshiki Takemoto, Tetsuya Mitsudomi, Masaya Nishino
Publikováno v:
Surgery Today. 51:1480-1487
Few studies have so far focused on the preoperative presence of venous thromboembolism (VTE) in lung cancer patients undergoing surgery. In this study, we investigated the prevalence and risk factors for preoperative deep venous thrombosis (DVT) in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::921d245b826c60a8f5e09267379777f2
https://doi.org/10.1007/s00595-021-02243-3
https://doi.org/10.1007/s00595-021-02243-3